

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.30949961 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 4.72636855 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 4.72636855 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 4.72636855 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.72636855 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.72636855 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.72636855 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.69989187 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.48897145 |
| 10 | response to peptidoglycan (GO:0032494) | 4.42810701 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.34291853 |
| 12 | negative regulation of cell killing (GO:0031342) | 4.34291853 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.32409663 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.30493833 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.18872409 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 4.13701749 |
| 17 | detection of other organism (GO:0098543) | 4.08670412 |
| 18 | response to muramyl dipeptide (GO:0032495) | 4.03672853 |
| 19 | detection of bacterium (GO:0016045) | 4.02051836 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.95776394 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 3.93021361 |
| 22 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.89530286 |
| 23 | positive thymic T cell selection (GO:0045059) | 3.85676364 |
| 24 | cellular extravasation (GO:0045123) | 3.72211435 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 3.67962841 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.65860713 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.59186265 |
| 28 | B cell receptor signaling pathway (GO:0050853) | 3.57627623 |
| 29 | negative thymic T cell selection (GO:0045060) | 3.52068797 |
| 30 | regulation of mast cell degranulation (GO:0043304) | 3.46697851 |
| 31 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.44902771 |
| 32 | positive regulation of B cell differentiation (GO:0045579) | 3.40885381 |
| 33 | detection of external biotic stimulus (GO:0098581) | 3.39508703 |
| 34 | regulation of leukocyte degranulation (GO:0043300) | 3.38157052 |
| 35 | negative T cell selection (GO:0043383) | 3.32686807 |
| 36 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.30795851 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 3.30298844 |
| 38 | germinal center formation (GO:0002467) | 3.28386126 |
| 39 | myeloid cell activation involved in immune response (GO:0002275) | 3.24281972 |
| 40 | NIK/NF-kappaB signaling (GO:0038061) | 3.23644347 |
| 41 | T cell selection (GO:0045058) | 3.22014768 |
| 42 | leukocyte aggregation (GO:0070486) | 3.20742142 |
| 43 | thymic T cell selection (GO:0045061) | 3.20667169 |
| 44 | mannose metabolic process (GO:0006013) | 3.20258788 |
| 45 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.14439251 |
| 46 | response to host immune response (GO:0052572) | 3.11258724 |
| 47 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.11258724 |
| 48 | pinocytosis (GO:0006907) | 3.10564971 |
| 49 | positive T cell selection (GO:0043368) | 3.09617550 |
| 50 | response to host (GO:0075136) | 3.08654892 |
| 51 | response to host defenses (GO:0052200) | 3.08654892 |
| 52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.08654892 |
| 53 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08169785 |
| 54 | negative regulation of granulocyte differentiation (GO:0030853) | 3.06676940 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.04687301 |
| 56 | detection of biotic stimulus (GO:0009595) | 3.03044851 |
| 57 | regulation of B cell differentiation (GO:0045577) | 3.02770244 |
| 58 | detection of molecule of bacterial origin (GO:0032490) | 3.02248920 |
| 59 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.95227790 |
| 60 | macrophage activation (GO:0042116) | 2.90790307 |
| 61 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.87229311 |
| 62 | positive regulation of mast cell activation (GO:0033005) | 2.86464120 |
| 63 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.79584990 |
| 64 | respiratory burst (GO:0045730) | 2.76328159 |
| 65 | regulation of tolerance induction (GO:0002643) | 2.75118807 |
| 66 | positive regulation of type 2 immune response (GO:0002830) | 2.74778303 |
| 67 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.73636515 |
| 68 | tolerance induction (GO:0002507) | 2.73587462 |
| 69 | regulation of mast cell activation (GO:0033003) | 2.73288749 |
| 70 | negative regulation of T cell mediated immunity (GO:0002710) | 2.72964594 |
| 71 | positive regulation of mast cell degranulation (GO:0043306) | 2.72268260 |
| 72 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.72268260 |
| 73 | B cell mediated immunity (GO:0019724) | 2.71479765 |
| 74 | response to laminar fluid shear stress (GO:0034616) | 2.71241408 |
| 75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.71218586 |
| 76 | microglial cell activation (GO:0001774) | 2.70797704 |
| 77 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.67147670 |
| 78 | regulation of antigen processing and presentation (GO:0002577) | 2.65981044 |
| 79 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.65891894 |
| 80 | T cell migration (GO:0072678) | 2.64495745 |
| 81 | response to type I interferon (GO:0034340) | 2.63455646 |
| 82 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.62955935 |
| 83 | cellular response to type I interferon (GO:0071357) | 2.62570715 |
| 84 | type I interferon signaling pathway (GO:0060337) | 2.62570715 |
| 85 | regulation of regulated secretory pathway (GO:1903305) | 2.62338763 |
| 86 | neutrophil activation (GO:0042119) | 2.61821365 |
| 87 | regulation of granulocyte differentiation (GO:0030852) | 2.60287349 |
| 88 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.59753191 |
| 89 | regulation of T cell tolerance induction (GO:0002664) | 2.58168788 |
| 90 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.57477505 |
| 91 | defense response to protozoan (GO:0042832) | 2.55672276 |
| 92 | positive regulation of antigen processing and presentation (GO:0002579) | 2.54583238 |
| 93 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.54183734 |
| 94 | regulation of type 2 immune response (GO:0002828) | 2.54016453 |
| 95 | negative regulation of interleukin-6 production (GO:0032715) | 2.53997945 |
| 96 | histone H3-K36 demethylation (GO:0070544) | 2.53181999 |
| 97 | positive regulation of granulocyte differentiation (GO:0030854) | 2.51394343 |
| 98 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.51351592 |
| 99 | positive regulation of interferon-alpha production (GO:0032727) | 2.51062131 |
| 100 | B cell homeostasis (GO:0001782) | 2.50448016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.27364054 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.37888933 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.08951352 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.86197593 |
| 5 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.78402254 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.72416459 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.67270537 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51365313 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.48191673 |
| 10 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.47570274 |
| 11 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.45815199 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.43389549 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39200583 |
| 14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.31633970 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.30375380 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29361855 |
| 17 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.26568563 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.25011973 |
| 19 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.23770826 |
| 20 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.23349863 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.21267999 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.17396201 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.08846885 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.08301244 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.08219196 |
| 26 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.05984149 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.03655150 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 2.02256924 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.01770758 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.98869385 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97392858 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.95616328 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93462406 |
| 34 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.90019165 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85477580 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.83212340 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.81729988 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.79055865 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76737240 |
| 40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75221065 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.74566254 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.70738931 |
| 43 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.66991058 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66210448 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60178254 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55725251 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.53095325 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.50723386 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.49986440 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.47307046 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.47256643 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46588841 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.44588931 |
| 54 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.41646674 |
| 55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.41283324 |
| 56 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.38745384 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.37316727 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36112308 |
| 59 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.31109375 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28582328 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28433748 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27958924 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27434265 |
| 64 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25208414 |
| 65 | P68_20966046_ChIP-Seq_HELA_Human | 1.25076302 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24908159 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23540649 |
| 68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22828187 |
| 69 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.22690204 |
| 70 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.21335741 |
| 71 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19924496 |
| 72 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18677602 |
| 73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17839617 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17830263 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16698421 |
| 76 | KDM2B_26808549_Chip-Seq_K562_Human | 1.16547908 |
| 77 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15675912 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15180667 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14864010 |
| 80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11762842 |
| 81 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.09768768 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08755117 |
| 83 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08052017 |
| 84 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06037909 |
| 85 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.04307227 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04004395 |
| 87 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03742682 |
| 88 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03416099 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00034419 |
| 90 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.99531087 |
| 91 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.97511330 |
| 92 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96302753 |
| 93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95071790 |
| 94 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94248362 |
| 95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93707704 |
| 96 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93479623 |
| 97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93337012 |
| 98 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92876921 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91792463 |
| 100 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91236922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.69131499 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.45727988 |
| 3 | MP0000685_abnormal_immune_system | 2.88453864 |
| 4 | MP0003303_peritoneal_inflammation | 2.79083400 |
| 5 | MP0002419_abnormal_innate_immunity | 2.64550200 |
| 6 | MP0001800_abnormal_humoral_immune | 2.56986760 |
| 7 | MP0005387_immune_system_phenotype | 2.55689168 |
| 8 | MP0001790_abnormal_immune_system | 2.55689168 |
| 9 | MP0003724_increased_susceptibility_to | 2.49767321 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.46651043 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.44347341 |
| 12 | MP0005025_abnormal_response_to | 2.42983805 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.40056266 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.36056268 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.31042761 |
| 16 | MP0005671_abnormal_response_to | 2.29175592 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.27548683 |
| 18 | MP0002723_abnormal_immune_serum | 2.23895479 |
| 19 | MP0009278_abnormal_bone_marrow | 2.18250188 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.16954422 |
| 21 | MP0001819_abnormal_immune_cell | 2.14565618 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.10599180 |
| 23 | MP0004947_skin_inflammation | 2.04981887 |
| 24 | MP0005451_abnormal_body_composition | 2.04062796 |
| 25 | MP0009785_altered_susceptibility_to | 2.01016006 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.90065396 |
| 27 | MP0006082_CNS_inflammation | 1.87390639 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.86313121 |
| 29 | MP0008260_abnormal_autophagy | 1.85255947 |
| 30 | MP0002396_abnormal_hematopoietic_system | 1.84591220 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.82836505 |
| 32 | MP0002405_respiratory_system_inflammati | 1.81699057 |
| 33 | MP0002398_abnormal_bone_marrow | 1.79488135 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.72517158 |
| 35 | MP0000716_abnormal_immune_system | 1.71965180 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.69193631 |
| 37 | MP0005076_abnormal_cell_differentiation | 1.58689725 |
| 38 | MP0003828_pulmonary_edema | 1.58343180 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.56516083 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.56516083 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.54884898 |
| 42 | MP0005310_abnormal_salivary_gland | 1.51542964 |
| 43 | MP0009840_abnormal_foam_cell | 1.51358241 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.50846090 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.50388211 |
| 46 | MP0002722_abnormal_immune_system | 1.50252480 |
| 47 | MP0001853_heart_inflammation | 1.48492678 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.47611793 |
| 49 | MP0002132_abnormal_respiratory_system | 1.47522867 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.46657603 |
| 51 | MP0002429_abnormal_blood_cell | 1.41908797 |
| 52 | MP0000858_altered_metastatic_potential | 1.37872858 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.36260006 |
| 54 | MP0003091_abnormal_cell_migration | 1.35729334 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.32356891 |
| 56 | MP0005410_abnormal_fertilization | 1.29817797 |
| 57 | MP0001873_stomach_inflammation | 1.28554395 |
| 58 | MP0008469_abnormal_protein_level | 1.27040828 |
| 59 | MP0003866_abnormal_defecation | 1.23037951 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.22155504 |
| 61 | MP0001851_eye_inflammation | 1.16580661 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.14935550 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 1.14237405 |
| 64 | MP0001348_abnormal_lacrimal_gland | 1.09809830 |
| 65 | MP0004883_abnormal_blood_vessel | 1.08382491 |
| 66 | MP0000604_amyloidosis | 1.08330935 |
| 67 | MP0003566_abnormal_cell_adhesion | 1.04719942 |
| 68 | MP0002933_joint_inflammation | 1.04327627 |
| 69 | MP0001958_emphysema | 1.03263076 |
| 70 | MP0003075_altered_response_to | 1.01882646 |
| 71 | MP0004381_abnormal_hair_follicle | 1.00788911 |
| 72 | MP0002009_preneoplasia | 0.99663168 |
| 73 | MP0003453_abnormal_keratinocyte_physiol | 0.99197777 |
| 74 | MP0005166_decreased_susceptibility_to | 0.98439958 |
| 75 | MP0004264_abnormal_extraembryonic_tissu | 0.96466955 |
| 76 | MP0005164_abnormal_response_to | 0.95685257 |
| 77 | MP0002006_tumorigenesis | 0.93819101 |
| 78 | MP0003448_altered_tumor_morphology | 0.92924111 |
| 79 | MP0009764_decreased_sensitivity_to | 0.90807422 |
| 80 | MP0000249_abnormal_blood_vessel | 0.90456620 |
| 81 | MP0001849_ear_inflammation | 0.89811688 |
| 82 | MP0005360_urolithiasis | 0.89550511 |
| 83 | MP0009115_abnormal_fat_cell | 0.88807957 |
| 84 | MP0005670_abnormal_white_adipose | 0.85617061 |
| 85 | MP0005390_skeleton_phenotype | 0.85122840 |
| 86 | MP0000490_abnormal_crypts_of | 0.84513952 |
| 87 | MP0004510_myositis | 0.83238446 |
| 88 | MP0005666_abnormal_adipose_tissue | 0.82973266 |
| 89 | MP0005409_darkened_coat_color | 0.79971382 |
| 90 | MP0008004_abnormal_stomach_pH | 0.78842941 |
| 91 | MP0005023_abnormal_wound_healing | 0.78732078 |
| 92 | MP0010234_abnormal_vibrissa_follicle | 0.74748947 |
| 93 | MP0003279_aneurysm | 0.72952836 |
| 94 | MP0003795_abnormal_bone_structure | 0.72489394 |
| 95 | MP0009763_increased_sensitivity_to | 0.70995700 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.69975401 |
| 97 | MP0000343_altered_response_to | 0.68920282 |
| 98 | MP0004185_abnormal_adipocyte_glucose | 0.68613394 |
| 99 | MP0003690_abnormal_glial_cell | 0.66010291 |
| 100 | MP0000609_abnormal_liver_physiology | 0.64590029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.03584850 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.25665377 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.23085788 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.18931185 |
| 5 | Recurrent fungal infections (HP:0002841) | 3.58522520 |
| 6 | Cellulitis (HP:0100658) | 3.50192690 |
| 7 | Myositis (HP:0100614) | 3.45992766 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.45124698 |
| 9 | Meningitis (HP:0001287) | 3.43411631 |
| 10 | Colitis (HP:0002583) | 3.33559546 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.30156980 |
| 12 | Increased IgE level (HP:0003212) | 3.26062549 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.24498750 |
| 14 | Recurrent cutaneous fungal infections (HP:0011370) | 3.24498750 |
| 15 | Recurrent viral infections (HP:0004429) | 3.24178802 |
| 16 | Agammaglobulinemia (HP:0004432) | 3.21413293 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.17043972 |
| 18 | Gingivitis (HP:0000230) | 3.14654591 |
| 19 | Recurrent skin infections (HP:0001581) | 3.12421054 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.11156128 |
| 21 | Obstructive lung disease (HP:0006536) | 3.05681524 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.05681524 |
| 23 | Orchitis (HP:0100796) | 3.04110037 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 3.01612537 |
| 25 | Gastrointestinal inflammation (HP:0004386) | 2.96384252 |
| 26 | Inflammation of the large intestine (HP:0002037) | 2.94363209 |
| 27 | Systemic lupus erythematosus (HP:0002725) | 2.82588575 |
| 28 | Increased cerebral lipofuscin (HP:0011813) | 2.75542703 |
| 29 | Gastrointestinal infarctions (HP:0005244) | 2.75161772 |
| 30 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.73790274 |
| 31 | Vasculitis (HP:0002633) | 2.70458108 |
| 32 | Optic neuritis (HP:0100653) | 2.68343209 |
| 33 | Retrobulbar optic neuritis (HP:0100654) | 2.68343209 |
| 34 | Dysostosis multiplex (HP:0000943) | 2.61994711 |
| 35 | Pustule (HP:0200039) | 2.51451796 |
| 36 | Spontaneous hematomas (HP:0007420) | 2.50955943 |
| 37 | Abnormality of glycolipid metabolism (HP:0010969) | 2.50165188 |
| 38 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.50165188 |
| 39 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.50165188 |
| 40 | Amyloidosis (HP:0011034) | 2.47937215 |
| 41 | Osteomyelitis (HP:0002754) | 2.46106685 |
| 42 | Prolonged bleeding time (HP:0003010) | 2.40752058 |
| 43 | Gastrointestinal stroma tumor (HP:0100723) | 2.34929790 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.32535635 |
| 45 | Epistaxis (HP:0000421) | 2.32522454 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.31323057 |
| 47 | Stomatitis (HP:0010280) | 2.27128291 |
| 48 | Urticaria (HP:0001025) | 2.25118959 |
| 49 | Granulocytopenia (HP:0001913) | 2.24745308 |
| 50 | Nasal polyposis (HP:0100582) | 2.24227126 |
| 51 | Encephalitis (HP:0002383) | 2.22169372 |
| 52 | Chest pain (HP:0100749) | 2.21307785 |
| 53 | Malnutrition (HP:0004395) | 2.20698707 |
| 54 | Asymmetric septal hypertrophy (HP:0001670) | 2.19322819 |
| 55 | Spondylolisthesis (HP:0003302) | 2.16700047 |
| 56 | Abnormality of the nasal mucosa (HP:0000433) | 2.14960481 |
| 57 | Abnormality of the fingertips (HP:0001211) | 2.14920401 |
| 58 | Papilloma (HP:0012740) | 2.14475329 |
| 59 | Verrucae (HP:0200043) | 2.14475329 |
| 60 | Polygenic inheritance (HP:0010982) | 2.12564078 |
| 61 | Recurrent pneumonia (HP:0006532) | 2.12351343 |
| 62 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.11569261 |
| 63 | Mucopolysacchariduria (HP:0008155) | 2.11569261 |
| 64 | Hemoptysis (HP:0002105) | 2.10412352 |
| 65 | T lymphocytopenia (HP:0005403) | 2.09218775 |
| 66 | Emphysema (HP:0002097) | 2.08706239 |
| 67 | Leukocytosis (HP:0001974) | 2.07651097 |
| 68 | Vacuolated lymphocytes (HP:0001922) | 2.06458631 |
| 69 | Recurrent lower respiratory tract infections (HP:0002783) | 2.05983552 |
| 70 | Gingival bleeding (HP:0000225) | 2.05880122 |
| 71 | Purpura (HP:0000979) | 2.05869301 |
| 72 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05704689 |
| 73 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05704689 |
| 74 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05704689 |
| 75 | Loss of speech (HP:0002371) | 2.05419649 |
| 76 | Peritonitis (HP:0002586) | 2.03141669 |
| 77 | Restrictive lung disease (HP:0002091) | 2.01860004 |
| 78 | Broad face (HP:0000283) | 2.01824769 |
| 79 | Abnormality of the peritoneum (HP:0002585) | 2.01339257 |
| 80 | Fatigue (HP:0012378) | 1.99579494 |
| 81 | Abnormality of T cells (HP:0002843) | 1.98359748 |
| 82 | Thin bony cortex (HP:0002753) | 1.98214164 |
| 83 | Skin ulcer (HP:0200042) | 1.97663074 |
| 84 | Keratoconjunctivitis sicca (HP:0001097) | 1.96691093 |
| 85 | Slow saccadic eye movements (HP:0000514) | 1.96371613 |
| 86 | Viral hepatitis (HP:0006562) | 1.94846740 |
| 87 | Interstitial pulmonary disease (HP:0006530) | 1.94118923 |
| 88 | Recurrent bronchitis (HP:0002837) | 1.93110171 |
| 89 | Abnormality of T cell number (HP:0011839) | 1.92622237 |
| 90 | Abnormality of T cell physiology (HP:0011840) | 1.92609373 |
| 91 | Hemorrhage of the eye (HP:0011885) | 1.91303619 |
| 92 | Autoimmune thrombocytopenia (HP:0001973) | 1.91075848 |
| 93 | Thoracic kyphosis (HP:0002942) | 1.90749048 |
| 94 | Arterial thrombosis (HP:0004420) | 1.90234476 |
| 95 | Sepsis (HP:0100806) | 1.89053803 |
| 96 | Lymphopenia (HP:0001888) | 1.86704200 |
| 97 | Myocardial infarction (HP:0001658) | 1.86324486 |
| 98 | Increased serum ferritin (HP:0003281) | 1.83417329 |
| 99 | Thrombocytosis (HP:0001894) | 1.83249425 |
| 100 | Hypertriglyceridemia (HP:0002155) | 1.80857200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.51070688 |
| 2 | ERN1 | 3.48788961 |
| 3 | RIPK4 | 3.34865686 |
| 4 | MAP4K1 | 3.23806723 |
| 5 | CDK12 | 2.65131295 |
| 6 | BLK | 2.57897493 |
| 7 | TRIB3 | 2.52305715 |
| 8 | TYK2 | 2.29410409 |
| 9 | MAP2K3 | 2.20838169 |
| 10 | MAP3K13 | 2.06330712 |
| 11 | MAP3K14 | 1.89127502 |
| 12 | SMG1 | 1.83907503 |
| 13 | ZAP70 | 1.77405090 |
| 14 | FES | 1.75497751 |
| 15 | IRAK4 | 1.71624825 |
| 16 | JAK3 | 1.70440960 |
| 17 | GRK6 | 1.59779695 |
| 18 | CSK | 1.57044640 |
| 19 | CSF1R | 1.54717341 |
| 20 | MAP3K3 | 1.51607952 |
| 21 | TBK1 | 1.51077278 |
| 22 | BTK | 1.45873254 |
| 23 | SIK1 | 1.44064305 |
| 24 | ICK | 1.40176808 |
| 25 | MAP3K10 | 1.36259309 |
| 26 | SYK | 1.35472631 |
| 27 | KIT | 1.31062792 |
| 28 | IRAK3 | 1.30815497 |
| 29 | MAP3K11 | 1.30421119 |
| 30 | IKBKE | 1.25431723 |
| 31 | PDPK1 | 1.22981153 |
| 32 | TNK2 | 1.22193732 |
| 33 | MAP3K1 | 1.22088553 |
| 34 | MARK2 | 1.19859807 |
| 35 | PDK1 | 1.16675151 |
| 36 | FGFR4 | 1.15631163 |
| 37 | HCK | 1.15371766 |
| 38 | JAK1 | 1.11054851 |
| 39 | BRD4 | 1.10557240 |
| 40 | CDC42BPA | 1.06319989 |
| 41 | EPHB1 | 1.05882990 |
| 42 | KSR2 | 1.04440867 |
| 43 | TGFBR2 | 0.99593758 |
| 44 | SIK2 | 0.99377620 |
| 45 | RIPK1 | 0.99063697 |
| 46 | EEF2K | 0.97135948 |
| 47 | SIK3 | 0.97049371 |
| 48 | TESK2 | 0.95999788 |
| 49 | TESK1 | 0.93540287 |
| 50 | IKBKB | 0.91256804 |
| 51 | LYN | 0.90105785 |
| 52 | MAPK11 | 0.87663232 |
| 53 | ITK | 0.87273437 |
| 54 | LCK | 0.86059741 |
| 55 | MAPK12 | 0.85355721 |
| 56 | STK10 | 0.84704912 |
| 57 | MAPK7 | 0.84509866 |
| 58 | JAK2 | 0.83873185 |
| 59 | MAP3K7 | 0.83092920 |
| 60 | TAOK1 | 0.82968066 |
| 61 | CDK4 | 0.80855151 |
| 62 | FGR | 0.80263617 |
| 63 | MAP2K2 | 0.79680780 |
| 64 | PRKD2 | 0.78583948 |
| 65 | PIK3CG | 0.78004449 |
| 66 | CDK6 | 0.77087321 |
| 67 | TAOK2 | 0.76254557 |
| 68 | FGFR3 | 0.75835380 |
| 69 | PKN2 | 0.73773559 |
| 70 | RPS6KL1 | 0.72794630 |
| 71 | RPS6KC1 | 0.72794630 |
| 72 | RPS6KA2 | 0.72473751 |
| 73 | TTN | 0.70991757 |
| 74 | STK38 | 0.70700428 |
| 75 | MST1R | 0.70502467 |
| 76 | TAOK3 | 0.66666995 |
| 77 | HIPK2 | 0.65210576 |
| 78 | MAP3K2 | 0.64374540 |
| 79 | PTK6 | 0.63998117 |
| 80 | DDR2 | 0.63111024 |
| 81 | MAP3K8 | 0.62285624 |
| 82 | IRAK2 | 0.62106726 |
| 83 | MAP3K6 | 0.62103689 |
| 84 | NEK9 | 0.60982857 |
| 85 | DYRK1B | 0.60889567 |
| 86 | MTOR | 0.60559361 |
| 87 | TXK | 0.60083531 |
| 88 | TEC | 0.57823369 |
| 89 | RPS6KA6 | 0.54808858 |
| 90 | BMPR2 | 0.51602977 |
| 91 | MARK3 | 0.50505863 |
| 92 | RET | 0.47954502 |
| 93 | MOS | 0.47477041 |
| 94 | MAPKAPK2 | 0.47246639 |
| 95 | CAMK1D | 0.45027866 |
| 96 | SGK3 | 0.44081636 |
| 97 | LRRK2 | 0.43809851 |
| 98 | IRAK1 | 0.43737067 |
| 99 | CDK9 | 0.43016232 |
| 100 | MATK | 0.43003283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.70415700 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.57875800 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.49962668 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.48657547 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.43955777 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.21613458 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.10265645 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.08732436 |
| 9 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.08705466 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.00267780 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.97297262 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83135000 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.78010569 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.77268591 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.68059064 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.67570877 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64807725 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.62588440 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.62526234 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.62487199 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.57452334 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.53779738 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52321943 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49991754 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.47879436 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.47679832 |
| 27 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.46472727 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.46427677 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.43303442 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.40299033 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.39804705 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.34364489 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.33090320 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.22357009 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.21994503 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.19225831 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18386682 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.18030165 |
| 39 | Lysosome_Homo sapiens_hsa04142 | 1.12876376 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.12612620 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12511705 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12302499 |
| 43 | Malaria_Homo sapiens_hsa05144 | 1.11890777 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10875630 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07789117 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06507226 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03399639 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.01161154 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 1.00138327 |
| 50 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99877661 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.98933190 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.98057637 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 0.97535748 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91779678 |
| 55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91600200 |
| 56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86704277 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85939014 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80297651 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.78427302 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77477602 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.76615002 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75574417 |
| 63 | Endometrial cancer_Homo sapiens_hsa05213 | 0.74353069 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73286211 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72267003 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72057117 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.71427199 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71048355 |
| 69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70629037 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70028880 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68046806 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66864825 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66433482 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.66287314 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 0.64460133 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.61999240 |
| 77 | Prostate cancer_Homo sapiens_hsa05215 | 0.61560506 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60731997 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59340428 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58103684 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58001843 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57714739 |
| 83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57519178 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56921786 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56112755 |
| 86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54023633 |
| 87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53934104 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53370336 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.53325636 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52998108 |
| 91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52511247 |
| 92 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.50163221 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49370688 |
| 94 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47093314 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.46753286 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45290097 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44836705 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44502665 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44259635 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42797892 |

